Health Tech Newsletter

Health Tech Newsletter February 6, 2025

New Teladoc, same acquisition strategy

The Readout

The Readout February 6, 2025

AstraZeneca offers some reassurance on China challenges 

advertisement

Adam's Take

Adam's Take February 6, 2025

STAT Plus: Previewing Immunovant’s myasthenia gravis study readout — with all its quirky nuance

Special Report

Special Report February 6, 2025

STAT Plus: The CRISPR companies are not OK

The Readout

The Readout February 5, 2025

This week in biotech earnings so far